Powell's dovish signals suggest calmed markets, while a collaboration between GoodRx and Novo Nordisk aims to provide popular medications at a lower cost.
2 reports, 2 independent
Updated Aug 19
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Powell's dovish signals suggest calmed markets, while a collaboration between GoodRx and Novo Nordisk aims to provide popular medications at a lower cost.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Jerome Powell
president of the FED
-
GoodRx
American prescription drug price tracking website and app
Nothing else this week.
-
Novo Nordisk
Danish pharmaceutical company
Coverage
Newest first; wire copies grouped- StockStoryWhy GoodRx (GDRX) Stock Is Trading Up Today Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 40.2% in the afternoon session after the company announced a collaboration with pharmaceutica
- BenzingaOzempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), al